Literature DB >> 9204289

The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?

A F Kaufmann1, M I Meltzer, G P Schmid.   

Abstract

Understanding and quantifying the impact of a bioterrorist attack are essential in developing public health preparedness for such an attack. We constructed a model that compares the impact of three classic agents of biologic warfare (Bacillus anthracis, Brucella melitensis, and Francisella tularensis) when released as aerosols in the suburb of a major city. The model shows that the economic impact of a bioterrorist attack can range from an estimated $477.7 million per 100,000 persons exposed (brucellosis scenario) to $26.2 billion per 100,000 persons exposed (anthrax scenario). Rapid implementation of a postattack prophylaxis program is the single most important means of reducing these losses. By using an insurance analogy, our model provides economic justification for preparedness measures.

Entities:  

Mesh:

Year:  1997        PMID: 9204289      PMCID: PMC2627615          DOI: 10.3201/eid0302.970201

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  13 in total

1.  Aerobiology.

Authors:  W S GOCHENOUR
Journal:  Mil Med       Date:  1963-02       Impact factor: 1.437

2.  Tularemia vaccine study. I. Intracutaneous challenge.

Authors:  S SASLAW; H T EIGELSBACH; H E WILSON; J A PRIOR; S CARHART
Journal:  Arch Intern Med       Date:  1961-05

3.  AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS.

Authors:  F R McCrumb
Journal:  Bacteriol Rev       Date:  1961-09

4.  The specter of biological weapons.

Authors:  L A Cole
Journal:  Sci Am       Date:  1996-12       Impact factor: 2.142

5.  Antibiotic prophylaxis and therapy of airborne tularemia.

Authors:  W D Sawyer; H G Dangerfield; A L Hogge; D Crozier
Journal:  Bacteriol Rev       Date:  1966-09

6.  The Sverdlovsk anthrax outbreak of 1979.

Authors:  M Meselson; J Guillemin; M Hugh-Jones; A Langmuir; I Popova; A Shelokov; O Yampolskaya
Journal:  Science       Date:  1994-11-18       Impact factor: 47.728

7.  Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital.

Authors:  J Staszkiewicz; C M Lewis; J Colville; M Zervos; J Band
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

8.  Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

Authors:  F A Abramova; L M Grinberg; O V Yampolskaya; D H Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Authors:  J Solera; M Rodríguez-Zapata; P Geijo; J Largo; J Paulino; L Sáez; E Martínez-Alfaro; L Sánchez; M A Sepulveda; M D Ruiz-Ribó
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Airborne spread of brucellosis.

Authors:  A F Kaufmann; M D Fox; J M Boyce; D C Anderson; M E Potter; W J Martone; C M Patton
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

View more
  85 in total

Review 1.  Bioterrorism: implications for the clinical microbiologist.

Authors:  W F Klietmann; K L Ruoff
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  The informatics response in disaster, terrorism, and war.

Authors:  Jonathan M Teich; Michael M Wagner; Colin F Mackenzie; Klaus O Schafer
Journal:  J Am Med Inform Assoc       Date:  2002 Mar-Apr       Impact factor: 4.497

3.  The space race and biodefense: lessons from NASA about big science and the role of medical informatics.

Authors:  Michael M Wagner
Journal:  J Am Med Inform Assoc       Date:  2002 Mar-Apr       Impact factor: 4.497

4.  Value of ICD-9 coded chief complaints for detection of epidemics.

Authors:  F C Tsui; M M Wagner; V Dato; C C Chang
Journal:  Proc AMIA Symp       Date:  2001

5.  Biological Warfare: Implications for Antimicrobial Use.

Authors:  Ethan Rubinstein; Itzhak Levi
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

6.  Accuracy of ICD-9-coded chief complaints and diagnoses for the detection of acute respiratory illness.

Authors:  J U Espino; M M Wagner
Journal:  Proc AMIA Symp       Date:  2001

Review 7.  Biological warfare and bioterrorism.

Authors:  Nicholas J Beeching; David A B Dance; Alastair R O Miller; Robert C Spencer
Journal:  BMJ       Date:  2002-02-09

8.  Hospital preparedness for victims of chemical or biological terrorism.

Authors:  D C Wetter; W E Daniell; C D Treser
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

9.  Rapid deployment of an electronic disease surveillance system in the state of Utah for the 2002 Olympic Winter Games.

Authors:  Per H Gesteland; Michael M Wagner; Wendy W Chapman; Jeremy U Espino; Fu-Chiang Tsui; Reed M Gardner; Robert T Rolfs; Virginia Dato; Brent C James; Peter J Haug
Journal:  Proc AMIA Symp       Date:  2002

10.  Data, network, and application: technical description of the Utah RODS Winter Olympic Biosurveillance System.

Authors:  Fu-Chiang Tsui; Jeremy U Espino; Michael M Wagner; Per Gesteland; Oleg Ivanov; Robert T Olszewski; Zhen Liu; Xiaoming Zeng; Wendy Chapman; Weng Keen Wong; Andrew Moore
Journal:  Proc AMIA Symp       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.